Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus (HBV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03476083
What this trial is testing

Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission

Who this might be right for
Hepatitis B InfectionCongenital MalformationBirth Defect+2 more
New Discovery LLC 280
Early research (Phase 1)UnknownNCT04480294
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Jiangsu HengRui Medicine Co., Ltd. 108
Testing effectiveness (Phase 2)Ended earlyNCT00040144
What this trial is testing

Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 85
Not applicableStudy completedNCT02108444
What this trial is testing

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

Who this might be right for
HepatitisHepatitis BLymphoma+1 more
Peking University 107
Not applicableUnknownNCT04980664
What this trial is testing

Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2,000
Early research (Phase 1)Study completedNCT02186977
What this trial is testing

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID

Who this might be right for
Hepatitis B
Novosanis NV 48
Large-scale testing (Phase 3)UnknownNCT01270165
What this trial is testing

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Yonsei University 110
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Post-approval studies (Phase 4)UnknownNCT01833611
What this trial is testing

Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT

Who this might be right for
Chronic Hepatitis
National Cheng-Kung University Hospital 130
Testing effectiveness (Phase 2)Study completedNCT01106092
What this trial is testing

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Who this might be right for
Haemophilus Influenzae Type bTetanusHepatitis B+3 more
GlaxoSmithKline 312
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Not applicableStudy completedNCT01813487
What this trial is testing

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

Who this might be right for
Chronic Hepatitis B
Genexine, Inc. 6
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Not applicableUnknownNCT03539016
What this trial is testing

Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT04365933
What this trial is testing

The Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

Who this might be right for
Hepatitis B, Chronic
Enyo Pharma 20
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT01340937
What this trial is testing

V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 2,808
Not applicableStudy completedNCT02025842
What this trial is testing

Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis B
Azienda Ospedaliera San Camillo Forlanini 306
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT01457495
What this trial is testing

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more
GlaxoSmithKline 312
Next Page